<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03506191</url>
  </required_header>
  <id_info>
    <org_study_id>RETROSTENO</org_study_id>
    <nct_id>NCT03506191</nct_id>
  </id_info>
  <brief_title>Pneumonia Due to Stenotrophomonas Maltophilia in ICUs</brief_title>
  <acronym>RETROSTENO</acronym>
  <official_title>Pneumonia Due to Stenotrophomonas Maltophilia in Intensive Care Units: a Multicentre Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Pitie-Salpetriere</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier Pitie-Salpetriere</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pneumonia is a major cause of ICU admission, or may complicate ICU course. Among the
      causative pathogens, Stenotrophomonas Maltophilia is a rare pathogen, but affects usually
      patients with chronic pulmonary co-morbidities, or with long duration of mechanical
      ventilation and multiples treatment with broad spectrum antimicrobial therapy. However, there
      are only a paucity of data regarding epidemiology, impact and outcome of Pneumonia due to
      Stenotrophomonas Maltophilia in critically ill patients.

      Primary objective was to study factors associated with mortality in case of Pneumonia due to
      Stenotrophomonas Maltophilia. Secondary objectives were to describe factors associated with
      morbidity of Pneumonia due to Stenotrophomonas Maltophilia (duration of mechanical
      ventilation, ICU length of stay), and to report the characteristics of critically ill
      patients presenting Pneumonia due to Stenotrophomonas Maltophilia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment failure</measure>
    <time_frame>Day 30</time_frame>
    <description>Treatment failure is defined as composite of death and recurrence of pneumonia due to Stenotrophomonas Maltophilia within 30 days of the first episode</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>Day 30</time_frame>
    <description>Number of days under mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of pneumonia due to Stenotrophomonas Maltophilia</measure>
    <time_frame>Day 30</time_frame>
    <description>New onset of pneumonia due to Stenotrophomonas Maltophilia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Day 30</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pneumonia, Ventilator-Associated</condition>
  <condition>Stenotrophomonas Infection</condition>
  <condition>Critical Illness</condition>
  <condition>Pneumonia, Bacterial</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized in Intensive Care Unit and presenting pneumonia due to
        Stenotrophomonas maltophilia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients older than 18 years

        Documented Stenotrophomonas maltophilia pneumonia:

          -  Clinical suspicion (≥ two criteria including: fever&gt; 38.5°C, leukocytosis &gt; 10^9/L or
             leukopenia &lt; 4.10^8/L, purulent tracheobronchial secretions and a new or persistent
             infiltrate on chest radiography).

          -  Documented Stenotrophomonas maltophilia positive quantitative culture of a respiratory
             sample: bronchoalveolar lavage fluid (significant threshold, &gt;10^4cfu/ml) or plugged
             telescopic catheter (significant threshold, &gt;10^3cfu/ml) or quantitative endotracheal
             aspirate (significant threshold, &gt;10^6cfu/ml).

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrien Bouglé, MD</last_name>
    <role>Study Director</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe Guerci, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU NANCY</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adrien Bouglé, MD</last_name>
    <phone>003342162991</phone>
    <email>adrien.bougle@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philippe Guerci, MD</last_name>
    <phone>003383157995</phone>
    <email>p.guerci@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Anesthesiology and Critical Care Medicine, Groupe Hospitalier Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrien Bouglé, MD</last_name>
      <phone>0033142162991</phone>
      <email>adrien.bougle@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Hugo Bellut, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Réanimation Polyvalente CHR Metz-Thionville</name>
      <address>
        <city>Metz</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Louis, MD</last_name>
    </contact>
    <investigator>
      <last_name>Guillaume Louis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology and Critical Care Medicine, University Hospital of NANCY</name>
      <address>
        <city>Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Guerci, MD</last_name>
      <phone>003383157995</phone>
      <email>p.guerci@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Guerci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire Charpentier</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mokthar Mokthari</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine Kimmoun</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology and Critical Care Medicine, University Hospital of Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Julien Pottecher, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Gaudefroy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2018</study_first_submitted>
  <study_first_submitted_qc>April 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2018</study_first_posted>
  <last_update_submitted>April 21, 2018</last_update_submitted>
  <last_update_submitted_qc>April 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Groupe Hospitalier Pitie-Salpetriere</investigator_affiliation>
    <investigator_full_name>Adrien Bouglé</investigator_full_name>
    <investigator_title>Study director</investigator_title>
  </responsible_party>
  <keyword>Stenotrophomonas maltophilia</keyword>
  <keyword>Pneumonia</keyword>
  <keyword>Intensive Care Unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Pneumonia, Bacterial</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

